Raphael Fraser, PhD

Publications

• Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden

  (Cornell RF, Fraser R, Costa L, Goodman S, Estrada-Merly N, Lee C, Hildebrandt G, Gergis U, Farhadfar N, Freytes CO, Kamble RT, Krem M, Kyle RA, Lazarus HM, Marks DI, Meehan K, Patel SS, Ramanathan M, Olsson RF, Wagner JL, Kumar S, Qazilbash MH, Shah N, Hari P, D'Souza A.) Transplantation and Cellular Therapy. March 2021;27(3):264.e1-264.e7 SCOPUS ID: 2-s2.0-85101183550 03/01/2021

• Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.

  (Dhakal B, Patel S, Girnius S, Bachegowda L, Fraser R, Davila O, Kanate AS, Assal A, Hanbali A, Bashey A, Pawarode A, Freytes CO, Lee C, Vesole D, Cornell RF, Hildebrandt GC, Murthy HS, Lazarus HM, Cerny J, Yared JA, Schriber J, Berdeja J, Stockerl-Goldstein K, Meehan K, Holmberg L, Solh M, Diaz MA, Kharfan-Dabaja MA, Farhadfar N, Bashir Q, Munker R, Olsson RF, Gale RP, Bayer RL, Seo S, Chhabra S, Hashmi S, Badawy SM, Nishihori T, Gonsalves W, Nieto Y, Efebera Y, Kumar S, Shah N, Qazilbash M, Hari P, D'Souza A.) Leukemia. 2020 12;34(12):3338-3347 PMID: 32313109 PMCID: PMC7572530 SCOPUS ID: 2-s2.0-85083712292 04/22/2020

• Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.

  (Dhakal B, D'Souza A, Callander N, Chhabra S, Fraser R, Davila O, Anderson K, Assal A, Badawy SM, Berdeja J, Cerny J, Comenzo R, Chakraborty R, Peter Gale R, Kamble R, Kharfan-Dabaja MA, Krem M, Ganguly S, Janakiram M, Kansagra A, Munker R, Murthy H, Patel S, Kumar S, Shah N, Qazilbash M, Hari P.) Br J Haematol. 2020 11;191(3):442-452 PMID: 33094839 PMCID: PMC7990054 SCOPUS ID: 2-s2.0-85088463591 10/24/2020

• Multimedia Evaluation of EMT-Paramedic Assessment and Management of Pediatric Respiratory Distress.

  (Schroter S, Thomas D, Nimmer M, Visotcky A, Fraser R, Colella MR, Browne LR.) Prehosp Emerg Care. 2020 Oct 07:1-11 PMID: 32870748 SCOPUS ID: 2-s2.0-85092334063 09/02/2020

• The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.

  (Muslu CS, Kopetsky M, Nimmer M, Visotcky A, Fraser R, Brousseau DC.) Pediatr Blood Cancer. 2020 09;67(9):e28268 PMID: 32614150 PMCID: PMC7674235 SCOPUS ID: 2-s2.0-85087314028 07/03/2020

• Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care.

  (Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM.) J Pediatr Hematol Oncol. 2020 08;42(6):412-413 PMID: 32404689 SCOPUS ID: 2-s2.0-85085583670 05/15/2020

• Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit.

  (Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC.) J Allergy Clin Immunol Pract. 2020 03;8(3):1126-1128.e1 PMID: 31586667 PMCID: PMC7332348 SCOPUS ID: 2-s2.0-85073824604 10/07/2019

• African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.

  (Badar T, Hari P, Dávila O, Fraser R, Wirk B, Dhakal B, Freytes CO, Rodriguez Valdes C, Lee C, Vesole DH, Malek E, Hildebrandt GC, Landau H, Murthy HS, Lazarus HM, Berdeja JG, Meehan KR, Solh M, Diaz MA, Kharfan-Dabaja MA, Callander NS, Farhadfar N, Bashir Q, Kamble RT, Vij R, Munker R, Kyle RA, Chhabra S, Hashmi S, Ganguly S, Jagannath S, Nishihori T, Nieto Y, Kumar S, Shah N, D'Souza A.) Cancer. 2020 Jan 01;127(1):82-92 PMID: 32966625 PMCID: PMC7736245 SCOPUS ID: 2-s2.0-85091313309 09/24/2020

• Racial disparities of liver cancer mortality in Wisconsin.

  (Bemanian A, Cassidy LD, Fraser R, Laud PW, Saeian K, Beyer KMM.) Cancer Causes Control. 2019 Dec;30(12):1277-1282 PMID: 31531799 PMCID: PMC6858574 SCOPUS ID: 2-s2.0-85073816952 09/19/2019

• Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).

  (Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J.) Lancet Haematol. 2019 Mar;6(3):e132-e143 PMID: 30824040 PMCID: PMC6503965 SCOPUS ID: 2-s2.0-85061920512 03/03/2019

• Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

  (Hahn, T.E., Wallace, P.K., Fraser, R., Fei, M., Tario, J.D., Howard, A., Zhang, Y., Blackwell, B., Brunstein, C.G., Efebera, Y.A. and Geller, N..) Biology of Blood and Marrow Transplantation , Volume 25 , Issue 3 , S4 - S6. 03/01/2019

• Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT)

  (Kilari, D., Hari, P., Qayed, M., Fraser, R., Davila, O., Kumar, S., Mark, T.M., Nieto, Y. and D'Souza, A..) Journal of Clinical Oncology. 2018 36:6_suppl, 572-572 07/01/2019